Cobalamin (vitamin B 12) regulation of PrP C, PrP C-mRNA and copper levels in rat central nervous system

Experimental Neurology

Volumn 233, Issue 1, 2012, Pages 380-390

  Scalabrino, Giuseppe ^a   Veber, Daniela ^a   Mutti, Elena ^a   Calligaro, Alberto ^b   Milani, Silvano ^a   Tredici, Giovanni ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Cerebrospinal fluid; Cobalamin deficiency; Epidermal growth factor; Normal prion protein; Octapeptide repeat region; Spinal cord; Tumor necrosis factor

Indexed keywords

ANTIBODY; COBALAMIN; COPPER; EPIDERMAL GROWTH FACTOR; MESSENGER RNA; MYELIN; NEUROPROTECTIVE AGENT; PRION 6H4 REGION ANTIBODY; PRION OCTAPEPTIDE REPEAT REGION ANTIBODY; PRION PROTEIN; PROTEINASE K; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; DRUG EFFICACY; LEUKONEUROPATHY; LIVER LEVEL; MALE; MOUSE; MYELINATION; NEUROPATHOLOGY; NEUROPATHY; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRION; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RAT; SPINAL CORD LESION; VITAMIN DEFICIENCY; WHITE MATTER;

ANALYSIS OF VARIANCE; ANIMALS; CENTRAL NERVOUS SYSTEM; COPPER; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GASTRECTOMY; GENE EXPRESSION REGULATION; LAPAROTOMY; MALE; NERVE FIBERS, MYELINATED; PRIONS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 84856228409     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.11.003     Document Type: Article

References (58)

1. Aguzzi A., Baumann F., Bremer J. The prion's elusive reason for being. Annu. Rev. Neurosci. 2008, 31:439-477.
2. Baumann F., Tolnay M., Brabeck C., Pahnke J., Kloz U., Niemann H.H., Heikenwalder M., Rülicke T., Bürkle A., Aguzzi A. Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J. 2007, 26:538-547.
3. C and its homologue Dpl. Trends Neurosci. 2002, 25:150-154.
4. Buccellato F.R., Miloso M., Braga M., Nicolini G., Morabito A., Pravettoni G., Tredici G., Scalabrino G. Myelinolytic lesions in spinal cord of cobalamin-deficient rats are TNF-α-mediated. FASEB J. 1999, 13:297-304.
5. Campbell I.L., Eddleston M., Kemper P., Oldstone M.B.A., Hobbs M.V. Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie. J. Virol. 1994, 68:2383-2387.
6. Chiesa R., Harris D.A. Prion diseases: what is the neurotoxic molecule?. Neurobiol. Dis. 2001, 8:743-763.
7. Cohen F.E., Prusiner S.B. Structural studies of prion proteins. Prion Biology and Diseases 1999, 191-228. Cold Spring Harbor Laboratory Press, New York. S.B. Prusiner (Ed.).
8. Edgeworth J.A., Sicilia A., Linehan J., Brandner S., Jackson G.S., Collinge J. A standardized comparison of commercially available prion decontamination reagents using the Standard Steel-Binding Assay. J. Gen. Virol. 2010, 92:718-726.
9. Flechsig E., Shmerling D., Hegyi I., Raeber A.J., Fischer M., Cozzio A., von Mering C., Aguzzi A., Weissmann C. Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. Neuron 2000, 27:399-408.
10. Hamilton P.W., Allen D.C. Morphometry in histopathology. J. Pathol. 1995, 175:369-379.
11. Hyman B.T., Gomez-Isla T., Irizarry M.C. Stereology: a practical primer for neuropathology. J. Neuropathol. Exp. Neurol. 1998, 57:305-310.
12. Kalra S., Ahuja R., Mutti E., Veber D., Seetharam S., Scalabrino G., Seetharam B. Cobalamin-mediated regulation of transcobalamin receptor levels in rat organs. Arch. Biochem. Biophys. 2007, 463:128-132.
13. Kovacs G.G., Budka H. Prion diseases: from protein to cell pathology. Am. J. Pathol. 2008, 172:555-565.
14. Kramer C.Y. Extension of multiple range tests to group means with unequal number of replications. Biometrics 1956, 12:307-310.
15. Krasemann S., Zerr I., Weber T., Poser S., Kretzschmar H., Hunsmann G., Bodemer W. Prion disease associated with a novel nine octapeptide repeat insertion in the PRNP gene. Mol. Brain Res. 1995, 34:173-176.
16. Kumar N., Gross J.B., Ahlskog J.E. Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration. Neurology 2004, 63:33-39.
17. Kuwahara C., Kubosaki A., Nishimura T., Nasu Y., Nakamura Y., Saeki K., Matsumoto Y., Onodera T. Enhanced expression of cellular prion protein gene by insulin or nerve growth factor in immortalized mouse neuronal precursor cell lines. Biochem. Biophys. Res. Commun. 2000, 268:763-766.
18. Li A., Piccardo P., Barmada S.J., Ghetti B., Harris D.A. Prion protein with an octapeptide insertion has impaired neuroprotective activity in transgenic mice. EMBO J. 2007, 26:2777-2785.
19. Linden R., Martins V.R., Prado M.A., Cammarota M., Izquierdo I., Brentani R.R. Physiology of the prion protein. Physiol. Rev. 2008, 88:673-728.
20. -δδCT method. Methods 2001, 25:402-408.
21. Magnaghi V., Veber D., Morabito A., Buccellato F.R., Melcangi R.C., Scalabrino G. Decreased GFAP-mRNA expression in spinal cord of cobalamin-deficient rats. FASEB J. 2002, 16:1820-1822.
22. Mead S. Prion disease genetics. Eur. J. Hum. Genet. 2006, 14:273-281.
23. Mead S., Webb T.E., Campbell T.A., Beck J., Linehan J.M., Rutherfoord S., Joiner S., Wadsworth J.D., Heckmann J., Wroe S., Doey L., King A., Collinge J. Inherited prion disease with 5-OPRI: phenotype modification by repeat length and codon 129. Neurology 2007, 69:730-738.
24. Mitteregger G., Vosko M., Krebs B., Xiang W., Kohlmannsperger V., Nölting S., Hamann G.F., Kretzschmar H.A. The role of the octarepeat region in neuroprotective function of the cellular prion protein. Brain Pathol. 2007, 17:174-183.
25. Moser M., Colello R.J., Pott U., Oesch B. Developmental expression of the prion protein gene in glial cells. Neuron 1995, 14:509-517.
26. Mutti E., Veber D., Stampachiacchiere B., Triaca V., Gammella E., Tacchini L., Aloe L., Scalabrino G. Cobalamin deficiency-induced down-regulation of p75-immunoreactive cell levels in rat central nervous system. Brain Res. 2007, 1157:92-99.
27. Mutti E., Magnaghi V., Veber D., Faroni A., Pece S., Di Fiore P.P., Scalabrino G. Cobalamin deficiency-induced changes of epidermal growth factor (EGF)-receptor expression and EGF levels in rat spinal cord. Brain Res. 2011, 1376:23-30.
28. Nishida N., Tremblay P., Sugimoto T., Shigematsu K., Shirabe S., Petromilli C., Erpel S.P., Nakaoke R., Atarashi R., Houtani T., Torchia M., Sakaguchi S., DeArmond S.J., Prusiner S.B., Katamine S. A mouse prion protein transgene rescues mice deficient for the prion protein gene from Purkinje cell degeneration and demyelination. Lab. Invest. 1999, 79:689-697.
29. Owen F., Poulter M., Collinge J., Leach M., Lofthouse R., Crow T.J., Harding A.E. A dementing illness associated with a novel insertion in the prion protein gene. Mol. Brain Res. 1992, 13:155-157.
30. Polymenidou M., Moos R., Scott M., Sigurdson C., Shi Y.-Z., Yajima B., Hafner-Bratkovic I., Jerala R., Hornemann S., Wuthrich K., Bellon A., Vey M., Garen G., James M.N.G., Kav N., Aguzzi A. The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes. PLoS One 2008, 3:e3872.
31. Prinz M., Montrasio F., Furukawa H., van der Haar M.E., Schwarz P., Rülicke T., Giger O.T., Häusler K.-G., Perez D., Glatzel M., Aguzzi A. Intrinsic resistance of oligodendrocytes to prion infection. J. Neurosci. 2004, 24:5974-5981.
32. Prusiner S.B. An introduction to prion biology and diseases. Prion Biology and Diseases 1999, 1-66. Cold Spring Harbor Laboratory Press, New York. S.B. Prusiner (Ed.).
33. C. J. Neurosci. 2005, 25:4879-4888.
34. Raeber A.J., Race R.E., Brandner S., Priola S.A., Sailer A., Bessen R.A., Mucke L., Manson J., Aguzzi A., Oldstone M.B.A., Weissmann C., Chesebro B. Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie. EMBO J. 1997, 16:6057-6065.
35. Riesner D. Molecular basis of prion diseases. J. Neurovirol. 2002, 8(Suppl. 2):8-20.
36. Sakaguchi S. Molecular biology of prion protein and its first homologous protein. J. Med. Invest. 2007, 54:211-223.
37. Satoh J., Kurohara K., Yukitake M., Kuroda Y. Constitutive and cytokine-inducible expression of prion protein gene in human neural cell lines. J. Neuropathol. Exp. Neurol. 1998, 57:131-139.
38. Sauer H., Wefer K., Vetrugno V., Pocchiari M., Gissel C., Sachinidis A., Hescheler J., Wartenberg M. Regulation of intrinsic prion protein by growth factors and TNF-α: the role of intracellular reactive oxygen species. Free Radic. Biol. Med. 2003, 35:586-594.
39. 12) revisited. J. Neuropathol. Exp. Neurol. 2001, 60:109-120.
40. 12 (cobalamin) neurotrophism in adult central nervous system: lessons learned from its deficiency. Prog. Neurobiol. 2009, 88:203-220.
41. Scalabrino G., Monzio-Compagnoni B., Ferioli M.E., Lorenzini E.C., Chiodini E., Candiani R. Subacute combined degeneration and induction of ornithine decarboxylase in spinal cords of totally gastrectomized rats. Lab. Invest. 1990, 62:297-304.
42. Scalabrino G., Lorenzini E.C., Monzio-Compagnoni B., Colombi R.P., Chiodini E., Buccellato F.R. Subacute combined degeneration in the spinal cords of totally gastrectomized rats. Ornithine decarboxylase induction, cobalamin status, and astroglial reaction. Lab. Invest. 1995, 72:114-123.
43. Scalabrino G., Buccellato F.R., Tredici G., Morabito A., Lorenzini E.C., Allen R.H., Lindenbaum J. Enhanced levels of biochemical markers for cobalamin deficiency in totally gastrectomized rats: uncoupling of the enhancement from the severity of spongy vacuolation in spinal cord. Exp. Neurol. 1997, 144:258-265.
44. 12 (cobalamin) in the rat central nervous system. FASEB J. 1999, 13:2083-2090.
45. 12 (cobalamin) in the rat central nervous system. J. Neuropathol. Exp. Neurol. 2000, 59:808-814.
46. Scalabrino G., Veber D., Mutti E. Experimental and clinical evidence of the role of cytokines and growth factors in the pathogenesis of acquired cobalamin-deficient leukoneuropathy. Brain Res. Rev. 2008, 59:42-54.
47. Solomon I.H., Schepker J.A., Harris D.A. Prion neurotoxicity: insights from prion protein mutants. Curr. Issues Mol. Biol. 2010, 12:51-61.
48. Stella R., Massimino M.L., Sorgato M.C., Bertoli A. Prion and TNFα. TAC(E)it agreement between the prion protein and cell signaling. Cell Cycle 2010, 9:4616-4621.
49. Tredici G., Buccellato F.R., Braga M., Cavaletti G., Ciscato P., Moggio M., Scalabrino G. Polyneuropathy due to cobalamin deficiency in the rat. J. Neurol. Sci. 1998, 156:18-29.
50. Tredici G., Buccellato F.R., Cavaletti G., Scalabrino G. Subacute combined degeneration in totally gastrectomized rats: an ultrastructural study. J. Submicrosc. Cytol. Pathol. 1998, 30:165-173.
51. Tsiroulnikov K., Chobert J.M., Haertlé T. Copper-dependent degradation of recombinant ovine prion protein. FEBS J. 2006, 273:1959-1965.
52. Wadsworth J.D.F., Collinge J. Molecular pathology of human prion disease. Acta Neuropathol. 2011, 121:69-77.
53. Waggoner D.J., Bartnikas T.B., Gitlin J.D. The role of copper in neurodegenerative disease. Neurobiol. Dis. 1999, 6:221-230.
54. Williams A.E., van Dam A.-M., Man-A-Hing W.K.H., Berkenbosch F., Eikelenboom P., Fraser H. Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice. Brain Res. 1994, 654:200-206.
55. Xu K., Wang X., Shi Q., Chen C., Tian C., Li X.L., Zhou R.M., Chu Y.L., Dong X.P. Human prion protein mutants with deleted inserted octarepeats undergo different pathways to trigger cell apoptosis. J. Mol. Neurosci. 2011, 43:225-234.
56. Yedidia Y., Horonchik L., Tzaban S., Yanai A., Taraboulos A. Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein. EMBO J. 2001, 20:5383-5391.
57. Yuan J., Kinter M., McGeehan J., Perry G., Kneale G., Gambetti P., Zou W.-Q. Concealment of epitope by reduction and alkylation in prion protein. Biochem. Biophys. Res. Commun. 2005, 326:652-659.
58. C expression: nerve growth factor (NGF) activates the prion gene promoter through the MEK1 pathway in PC12 cells. Neurosci. Lett. 2006, 400:58-62.